The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bitterman Kevin since year 2005.
The trader's CIK number is 1591747.
At the time of this reporting, Bitterman Kevin is the Director of Editas Medicine, Inc. .
(stock ticker symbol EDIT).
See this page for all insider trading activities at Editas Medicine, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-05-22||EDIT||Editas Medicine, Inc.||Sale||1,000,000||17.00||17,000,000|
|2016-12-07||EDIT||Editas Medicine, Inc.||Sale||75,000||15.82||1,186,500|
|2016-12-05||EDIT||Editas Medicine, Inc.||Sale||80,000||15.74||1,259,200|
|2016-12-06||EDIT||Editas Medicine, Inc.||Sale||50,000||15.87||793,500|
|2016-11-23||EDIT||Editas Medicine, Inc.||Sale||21,480||15.71||337,450|
|2016-11-22||EDIT||Editas Medicine, Inc.||Sale||12,819||15.77||202,155|
|2016-11-16||EDIT||Editas Medicine, Inc.||Sale||30,830||16.30||502,529|
|2016-11-14||EDIT||Editas Medicine, Inc.||Sale||58,035||17.16||995,880|
|2016-11-15||EDIT||Editas Medicine, Inc.||Sale||30,865||17.16||529,797|
|2016-09-08||EDIT||Editas Medicine, Inc.||Sale||500,000||16.80||8,400,000|
|2014-02-10||GNCA||Genocea Biosciences, Inc.||Buy||232,820||12.00||2,793,840|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bitterman Kevin (Director of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.